All Clinical Trials

A listing of 23176 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Trials

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Offer

Lose Weight with GLP-1 Medications

Recruiting

Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.

As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab

NCT06880744

Recruiting

Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine).This study will evaluate how safe and effective risankizumab is compared to vedolizumab in treating adult participants with moderate to severe UC who are naive to targeted therapies (TaTs). Risankizumab and vedolizumab are approved medications for moderate to severe UC in multiple countries. Participants who meet the eligibility criteria... Read More

Gender:

ALL

Ages:

Between 18 years and 80 years

Trial Updated:

07/29/2025

Locations: Gastro Care Institute /ID# 274873, Lancaster, California +42 locations

Gastro Care Institute /ID# 274873, Lancaster, California

Clinical Applications Laboratories - San Diego - 3rd Avenue /ID# 273527, San Diego, California

Novum Research /ID# 273587, Clermont, Florida

Hillcrest Medical Research /ID# 273593, DeLand, Florida

Sanchez Clinical Research /ID# 273727, Miami, Florida

Endoscopic Research, Inc. /ID# 273548, Orlando, Florida

Gi Alliance - Glenview /ID# 274270, Glenview, Illinois

Illinois Gastroenterology Group /ID# 274280, Gurnee, Illinois

Southwest Gastroenterology - Oak Lawn /ID# 273596, Oak Lawn, Illinois

Springfield Clinic Main Campus /ID# 273547, Springfield, Illinois

Cotton O'Neil Digestive Health Center /ID# 274394, Topeka, Kansas

Tandem Clinical Research - Houma /ID# 274562, Houma, Louisiana

Metropolitan Gastroenterology Associates - Metairie /ID# 274282, Metairie, Louisiana

Pinnacle Gastroenterology /ID# 274991, Shreveport, Louisiana

Velocity Clinical Research, Rockville /ID# 273599, Rockville, Maryland

Gi Associates - Gia And Endoscopy Center - Flowood /ID# 274285, Flowood, Mississippi

Delta Gastroenterology & Endoscopy Center /ID# 275005, Southaven, Mississippi

New York Gastroenterology Associates - Upper East Side /ID# 273520, New York, New York

Digestive Health Partners - Biltmore Office /ID# 273594, Asheville, North Carolina

Gastro Health /ID# 275082, Cincinnati, Ohio

Digestive Disease Associates, LTD - Wyomissing /ID# 273603, Wyomissing, Pennsylvania

Gastroenterology Associates of Orangeburg /ID# 274559, Orangeburg, South Carolina

Gastro One - Walnut Run Road /ID# 273551, Cordova, Tennessee

Quality Medical Research /ID# 273733, Nashville, Tennessee

Amel Med /ID# 276439, Georgetown, Texas

Digestive & Liver Disease Consultants /ID# 276454, Houston, Texas

Linq Research /ID# 274917, Pearland, Texas

Tyler Research Institute, LLC /ID# 273585, Tyler, Texas

Care Access - Ogden /ID# 274361, Ogden, Utah

Gi Alliance - Bellevue /ID# 274264, Bellevue, Washington

Washington Gastroenterology - Tacoma /ID# 274551, Tacoma, Washington

Ordensklinikum Linz GmbH Barmherzige Schwestern /ID# 274318, Linz, Oberoesterreich

Toronto Immune & Digestive Health Institute /ID# 274259, Toronto, Ontario

Diex Recherche Quebec Inc. /ID# 274268, Quebec, Not set

Assuta Ashdod Medical Center /ID# 274686, Ashdod, HaDarom

Yitzhak Shamir Medical Center /ID# 275525, Zerifin, HaMerkaz

The Chaim Sheba Medical Center /ID# 273348, Ramat Gan, Tel-Aviv

Tel Aviv Sourasky Medical Center /ID# 273351, Tel Aviv, Tel-Aviv

Rambam Health Care Campus /ID# 273347, Haifa, Not set

Caribbean Medical Research Center /ID# 274832, San Juan, Not set

Kantonsspital St.Gallen /ID# 273382, St. Gallen, Sankt Gallen

Inselspital, Universitaetsspital Bern /ID# 273364, Bern, Not set

China Medical University Hospital /ID# 273641, Taichung, Not set

Conditions: Ulcerative Colitis

Learn More ›

Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 )

NCT06939036

Recruiting

This study aims to determine safety, tolerability, recommended phase 2 dose (RP2D), and preliminary antitumor activity of 225Ac-SSO110 with standard of care (SoC) therapy in patients with somatostatin receptor 2 expressing (SSTR2+) extensive-stage small cell lung cancer (ES-SCLC) and recurrent locally advanced or metastatic Merkel cell carcinoma (MCC).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/29/2025

Locations: Biogenix Molecular, Miami, Florida +3 locations

Conditions: Small Cell Lung Cancer Extensive Stage, Merkel Cell Carcinoma

Learn More ›

Pivotal Study for the Cardiac Performance System (CPS)

NCT06870591

Recruiting

This multi-center, observational study evaluates the accuracy of the Cardiac Performance System (CPS), a non-invasive device, for measuring hemodynamic parameters in adult patients undergoing clinically indicated right heart catheterization. The study compares CPS measurements to invasive measurements to assess agreement and potential clinical utility.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/29/2025

Locations: Huntsville Hospital Heart Center, Huntsville, Alabama +3 locations

Conditions: Cardiovascular Diseases

Learn More ›

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

NCT06782490

Recruiting

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986368 in participants with Multiple Sclerosis Spasticity

Gender:

ALL

Ages:

Between 18 years and 70 years

Trial Updated:

07/29/2025

Locations: Local Institution - 0050, Scottsdale, Arizona +48 locations

Local Institution - 0050, Scottsdale, Arizona

Local Institution - 0017, Aurora, Colorado

Local Institution - 0015, Tampa, Florida

Local Institution - 0016, Kansas City, Kansas

Neurology Center of New England, Foxboro, Massachusetts

Local Institution - 0018, Saint Louis, Missouri

University of Cincinnati Medical Center, Cincinnati, Ohio

Local Institution - 0039, Columbus, Ohio

Hope Neurology, Knoxville, Tennessee

Local Institution - 0001, Kirkland, Washington

Local Institution - 0005, Newcastle, New South Wales

Local Institution - 0004, Sydney, New South Wales

Local Institution - 0030, Kent Town, South Australia

Local Institution - 0007, Box Hill, Victoria

Austin Health, Heidelberg, Victoria

Local Institution - 0006, Parkville, Victoria

Perron Institute, Nedlands, Western Australia

Local Institution - 0013, Edmonton, Alberta

Local Institution - 0024, London, Ontario

Local Institution - 0012, Ottawa, Ontario

Local Institution - 0028, Toronto, Ontario

Local Institution - 0014, Lévis, Quebec

Local Institution - 0029, Montreal, Quebec

Local Institution - 0055, Brno, Brno-město

Local Institution - 0010, Hradec Kralove, Hradec Králové

Local Institution - 0054, Prague, Praha 2

Local Institution - 0059, Prague, Praha 4

Local Institution - 0011, Praha, Praha 5

Local Institution - 0053, Pardubice, Not set

Local Institution - 0009, Teplice, Ústecký Kraj

Local Institution - 0052, Wuerzburg, Bayern

Local Institution - 0022, Kassel, Hessen

Local Institution - 0027, Bochum, Nordrhein-Westfalen

Local Institution - 0060, Münster, Nordrhein-Westfalen

Local Institution - 0031, Meisenheim, Rheinland-Pfalz

Local Institution - 0023, Jena, Thüringen

Local Institution - 0051, Bielefeld, Not set

Local Institution - 0021, Dresden, Not set

Local Institution - 0020, Essen, Not set

Local Institution - 0057, Bydgoszcz, Kujawsko-pomorskie

Local Institution - 0044, Bydgoszcz, Kujawsko-pomorskie

Local Institution - 0046, Kraków, Małopolskie

Local Institution - 0056, Kraków, Małopolskie

Local Institution - 0048, Oswiecim, Małopolskie

Local Institution - 0047, Warszawa, MZ

Local Institution - 0061, Gdańsk, Not set

Local Institution - 0051, Slomniki, Not set

Local Institution - 0045, Katowice, Śląskie

Puerto Rico Multiple Sclerosis Center, Caguas, Not set

Conditions: Multiple Sclerosis Spasticity

Learn More ›

ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting

NCT06758011

Recruiting

This study aims to determine the feasibility of using the ivWatch (registered trademark) device to determine if there is an infiltration at the site of a peripheral intravenous (PIV) catheter. An infiltration is when the IV fluid leaks out of a vein and into the surrounding tissue. If medication starts leaking outside the vein, it can cause damage to the surrounding tissue. Using the ivWatch device may identify leaking fluid before the nurse is able to visually observe the signs or symptoms of t... Read More

Gender:

ALL

Ages:

Between 18 years and 95 years

Trial Updated:

07/29/2025

Locations: Roswell Park Comprehensive Cancer Center, Buffalo, New York

Conditions: Oncology, Extravasation

Learn More ›

Dyadic Life Review Intervention for Older Patients With Advanced Cancer) and Their Caregivers

NCT06505122

Recruiting

The purpose of this study is to test the feasibility of a pilot Randomized Controlled Trial (RCT) comparing Dyadic Life Review (DLR) intervention in older adults with advanced cancer and their caregivers to Care-as-Usual (CAU) group, which involves a referral to social work.

Gender:

ALL

Ages:

50 years and above

Trial Updated:

07/29/2025

Locations: University of Rochester, Rochester, New York

Conditions: Cancer

Learn More ›

ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours

NCT06597721

Recruiting

Adcendo ApS is conducting a phase 1 study of an investigational drug called ADCE-T02 (previously known as AMT-754), a tissue factor targeted antibody-drug conjugate which may be used in the future as a possible treatment for advanced solid tumors. The main purpose of the study is to determine the Maximum Tolerated Dose (MTD), the recommended dose and the safety and tolerability of ADCE-T02 when given as a single therapy over a range of different dose levels.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/29/2025

Locations: Yale University Cancer Center, New Haven, Connecticut +6 locations

Conditions: Advanced Solid Tumor

Learn More ›

Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria

NCT06865651

Recruiting

The purpose of this study is to explore the effect and Mechanism of Action (MoA) of remibrutinib (LOU064) vs. placebo on clinical outcomes in participants with Chronic Urticaria (CU), including both Chronic Spontaneous Urticaria (CSU) and Chronic Inducible Urticaria (CINDU).

Gender:

ALL

Ages:

Between 18 years and 100 years

Trial Updated:

07/29/2025

Locations: Ziaderm Research LLC, North Miami Beach, Florida +16 locations

Conditions: Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU)

Learn More ›

Hirschsprung Disease Genetic Study

NCT00478712

Recruiting

Hirschsprung disease is a genetic condition caused by lack of nerve cells in varying lengths of the intestines. This study will investigate the complex genetic basis of the disease, which involves multiple interacting genetic factors.

Gender:

ALL

Ages:

Between 1 week and 100 years

Trial Updated:

07/29/2025

Locations: New York University School of Medicine, New York, New York

Conditions: Hirschsprung Disease

Learn More ›

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

NCT06618287

Recruiting

The purpose of this study is to evaluate the safety, tolerability, drug levels, and preliminary efficacy of BMS-986507 combinations in adult participants with advanced solid tumors.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/29/2025

Locations: Local Institution - 0066, Birmingham, Alabama +46 locations

Local Institution - 0066, Birmingham, Alabama

University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami, Florida

Local Institution - 0065, Iowa City, Iowa

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey

Cleveland Clinic, Cleveland, Ohio

Local Institution - 0052, Portland, Oregon

Local Institution - 0014, Pittsburgh, Pennsylvania

Swedish Medical Center, Seattle, Washington

Liverpool Hospital, Liverpool, New South Wales

Princess Alexandra Hospital, Woolloongabba, Queensland

Cross Cancer Institute, Edmonton, Alberta

Local Institution - 0064, Newmarket, Ontario

Local Institution - 0023, Ottawa, Ontario

The Ottawa Hospital - General Campus, Ottawa, Ontario

Jewish General Hospital, Montreal, Quebec

Centre Hospitalier de l'Université de Montréal, Montréal, Quebec

Local Institution - 0048, Santiago, Región Metropolitana De Santiago

Local Institution - 0049, Santiago, Región Metropolitana De Santiago

Local Institution - 0047, Santiago, Región Metropolitana De Santiago

Local Institution - 0043, Bordeaux, Aquitaine

Local Institution - 0045, Marseille, Bouches-du-Rhône

Local Institution - 0053, Montpellier, Hérault

Local Institution - 0050, Lyon, Rhône-Alpes

Local Institution - 0041, Villejuif, Val-de-Marne

Local Institution - 0054, Paris, Not set

Local Institution - 0040, Paris, Not set

Local Institution - 0034, Aviano, Friuli-Venezia Giulia

Local Institution - 0033, Milan, Lombardia

Local Institution - 0056, Candiolo, Torino

Local Institution - 0035, Firenze, Toscana

Local Institution - 0032, Roma, Not set

Leids Universitair Medisch Centrum, Leiden, Zuid-Holland

Nederlands Kanker Instituut Antoni van Leeuwenhoek (NKI AVL), Amsterdam, Not set

Local Institution - 0062, Santiago de Compostela, A Coruña [La Coruña]

Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona]

Local Institution - 0058, Hospitalet, Barcelona [Barcelona]

Local Institution - 0059, Barcelona, Catalunya [Cataluña]

Hospital Universitario 12 de Octubre, Madrid, Madrid, Comunidad De

Local Institution - 0061, Majadahonda, Madrid, Comunidad De

Hospital Universitario Fundación Jiménez Díaz, Madrid, Not set

Hospital Universitario HM Sanchinarro, Madrid, Not set

Local Institution - 0063, Málaga, Not set

Local Institution - 0060, València, Not set

Royal Free Hospital, London, England

Local Institution - 0021, Glasgow, Glasgow City

University Hospitals Birmingham NHS Foundation Trust, Birmingham, West Midlands

Local Institution - 0001, Newcastle upon Tyne, Not set

Conditions: Lung Cancer

Learn More ›

Cannabis for Palliative Care in Cancer

NCT06266611

Recruiting

Many cancer patients suffer from pain, sleep, and mood problems and are using cannabis to relieve these symptoms. Cannabis may provide such relief but may also produce negative side effects including cognitive impairment, an especially problematic issue for cancer patients, indicating more research on cannabis use in the cancer context is required. In this endeavor, the present study seeks to compare the use of hemp-derived CBD (Cannabidiol) with and without THC (Delta-9-tetrahydrocannabinol) ve... Read More

Gender:

ALL

Ages:

25 years and above

Trial Updated:

07/29/2025

Locations: Anschutz Health Sciences Building, Aurora, Colorado

Conditions: Sleep, Anxiety, Depression, Pain

Learn More ›

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

NCT06561386

Recruiting

The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy in participants with stage IV or recurrent Non-squamous Non-small Cell Lung Cancer with PD-L1 expression ≥ 1%

Gender:

ALL

Ages:

18 years and above

Trial Updated:

07/29/2025

Locations: Southern Arizona VA Health Care System, Tucson, Arizona +274 locations

Southern Arizona VA Health Care System, Tucson, Arizona

Local Institution - 0112, Los Angeles, California

University of California Davis (UC Davis) Comprehensive Cancer Center, Sacramento, California

San Francisco Oncology Associates, San Francisco, California

UCLA Hematology/Oncology - Santa Monica, Santa Monica, California

University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami, Florida

Memorial Hospital West, Pembroke Pines, Florida

Florida Cancer Specialists - North, Saint Petersburg, Florida

Florida Cancer Specialists - East, West Palm Beach, Florida

Affiliated Oncologists, LLC, Chicago Ridge, Illinois

Saint Elizabeth Medical Center Edgewood, Edgewood, Kentucky

Hattiesburg Clinic Hematology/Oncology, Hattiesburg, Mississippi

Local Institution - 0308, Bozeman, Montana

Renown Regional Medical Center, Reno, Nevada

St. Joseph's Regional Medical Center, Paterson, New Jersey

New Mexico VA Healthcare System, Albuquerque, New Mexico

Local Institution - 0357, Bronx, New York

WMCHealth Advanced Physician Services, Hawthorne, New York

Veterans Affairs New York Harbor Healthcare System, New York, New York

Local Institution - 0380, Northport, New York

Local Institution - 0325, Rochester, New York

Local Institution - 0324, Syracuse, New York

Messino Cancer Centers, Asheville, North Carolina

Local Institution - 0351, Greenville, North Carolina

Local Institution - 0369, Canton, Ohio

University of Cincinnati Medical Center, Cincinnati, Ohio

Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio

Local Institution - 0366, Massillon, Ohio

Lancaster General Hospital - Ann B Barshinger Cancer Institute, Lancaster, Pennsylvania

Texas Oncology - West Texas, Abilene, Texas

Local Institution - 0305, Harlingen, Texas

University of Texas MD Anderson Cancer Center, Houston, Texas

The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center, Tyler, Texas

Local Institution - 0302, Salt Lake City, Utah

Hospital Británico de Buenos Aires, Ciudad autónoma de Buenos Aires, Buenos Aires

Instituto Alexander Fleming, Ciudad Autónoma de Buenos Aires, Buenos Aires

Hospital Italiano de Buenos Aires, ABB, Ciudad Autónoma De Buenos Aires

Instituto Médico Río Cuarto, Río Cuarto, Córdoba

Sanatorio Parque, Rosario, Santa Fe

Hospital Privado Universitario de Córdoba, Córdoba, Not set

Instituto Oncológico de Córdoba, Córdoba, Not set

Hospital Privado de Comunidad, Mar del Plata, Not set

Gosford Hospital, Gosford, New South Wales

GenesisCare North Shore, St Leonards, New South Wales

The Prince Charles Hospital, Brisbane, Queensland

Gallipoli Medical Research Ltd, Brisbane, Queensland

Local Institution - 0057, Elizabeth Vale, South Australia

Box Hill Hospital, Box Hill, Victoria

Fiona Stanley Hospital, Murdoch, Western Australia

St. John of God Murdoch Hospital, Murdoch, Western Australia

Local Institution - 0314, Krems, Niederösterreich

Local Institution - 0292, Wels, Oberösterreich

Local Institution - 0293, Wien, Not set

Antwerp University Hospital, Edegem, Antwerpen

UZ Brussel, Brussels, Bruxelles-Capitale, Région De

Jessa Ziekenhuis, Hasselt, Limburg

Université Catholique de Louvain-Namur - Centre Hospitalier Universitaire Dinant-Godinne - Site Godinne, Yvoir, Namur

AZ Delta vzw, Roeselare, West-Vlaanderen

Centre Hospitalier Universitaire de Liège - Domaine Universitaire du Sart Tilman, Liège, Not set

Pronutrir, Fortaleza, Ceará

Cetus Oncologia - Unidade Belo Horizonte, Belo Horizonte, Minas Gerais

Local Institution - 0375, Belem, Pará

Liga Norte Riograndense Contra o Câncer, Natal, Rio Grande Do Norte

Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul

Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul

Clínica de Neoplasias Litoral, Itajaí, Santa Catarina

Fundação Pio XII - Hospital de Câncer de Barretos, Barretos, São Paulo

NAIC - Instituto do Câncer, Bauru, São Paulo

Centro de Oncologia - CEON+ - Unidade São Caetano do Sul, São Caetano do Sul, São Paulo

Instituto Nacional de Câncer - INCA, Rio de Janeiro, Not set

Icesp - Instituto Do Câncer Do Estado de São Paulo, São Paulo, Not set

Orlandi Oncologia, Santiago, Región Metropolitana De Santiago

Fundacion Arturo Lopez Perez (FALP), Santiago, Región Metropolitana De Santiago

Pontificia Universidad Catolica de Chile, Santiago, Región Metropolitana De Santiago

Bradfordhill, Santiago, Región Metropolitana De Santiago

Oncocentro Apys, Viña del Mar, Valparaíso

Local Institution - 0182, Hefei, Anhui

Beijing Cancer hospital, Beijing, Beijing

Chongqing University Cancer Hospital, Chongqing, Chongqing

Chongqing Three Gorges Central Hospital, Wanzhou, Chongqing

Fujian Cancer Hospital, Fuzhou, Fujian

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong

Huizhou Central People's Hospital, Huizhou, Guangdong

Liuzhou People's Hospital, Liuzhou, Guangxi

Guangxi Medical University Affiliated Tumor Hospital, Nanning, Guangxi

Harbin Medical University Cancer Hospital, Harbin, Heilongjiang

Local Institution - 0420, Xinxiang, Henan

The First Affiliated Hospital of Zhengzhou Universtiy, Zhengzhou, Henan

Local Institution - 0235, Wuhan, Hubei

Hunan Cancer Hospital, Changsha, Hunan

First Huai'an Hospital Affiliated to Nanjing Medical University, Huai'an, Jiangsu

Local Institution - 0451, Nanchang, Jiangxi

Liaoning Cancer Hospital, Shenyang, Liaoning

Xi'an International Medical Center Hospital, Xi'an, Shaanxi

Shandong Cancer Hospital, Jinan, Shandong

Shanghai Chest Hospital, Shanghai, Shanghai

Zhongshan Hospital,Fudan University, Shanghai, Shanghai

Local Institution - 0435, Taiyuan, Shanxi

Sichuan Cancer hospital, Chengdu, Sichuan

The Second People's Hospital of Neijiang, Neijiang, Sichuan

Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin

The first Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang

Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang

Zhejiang Cancer Hospital, Hangzhou, Zhejiang

Taizhou Hospital of Zhejiang Province, Linhai, Zhejiang

Guangdong Provincial People's Hospital, Guangzhou, Not set

Local Institution - 0415, Medellín, Antioquia

Local Institution - 0417, Valledupar, Cesar

Local Institution - 0443, Bogotá, Distrito Capital De Bogotá

Local Institution - 0418, Bogotá, Distrito Capital De Bogotá

Local Institution - 0416, Pereira, Risaralda

Local Institution - 0442, Cali, Valle Del Cauca

Aarhus Universitetshospital, Skejby, Aarhus, Midtjylland

Local Institution - 0124, Soenderborg, Syddanmark

Local Institution - 0125, Copenhagen, Not set

Local Institution - 0462, Brest, Finistère

Local Institution - 0090, Toulouse, Haute-Garonne

Local Institution - 0092, Montpellier, Hérault

Local Institution - 0093, Rennes, Ille-et-Vilaine

Centre Hospitalier Régional Universitaire de Nancy - Hôpitaux de Brabois, Vandoeuvre lès Nancy, Meurthe-et-Moselle

Local Institution - 0096, Lille, Nord-Pas-de-Calais

Centre Hospitalier intercommunal de Toulon La Seyne sur Mer, Toulon, Provence-Alpes-Côte-d'Azur

Local Institution - 0157, Pierre-Bénite, Rhône

Centre Hospitalier de la Côte Basque, Bayonne, Not set

Local Institution - 0158, Marseille, Not set

Local Institution - 0089, Paris, Not set

Local Institution - 0095, Paris, Not set

Local Institution - 0284, Esslingen, Baden-Württemberg

Local Institution - 0439, Ulm, Baden-Württemberg

Local Institution - 0287, Kempten, Bayern

Local Institution - 0347, München, Bayern

Local Institution - 0313, Marburg, Hessen

Local Institution - 0436, Hannover, Niedersachsen

Local Institution - 0397, Herne, Nordrhein-Westfalen

Local Institution - 0438, Münster, Nordrhein-Westfalen

Local Institution - 0437, Chemnitz, Sachsen

Local Institution - 0316, Grosshansdorf, Schleswig-Holstein

Local Institution - 0285, Berlin, Not set

Local Institution - 0282, Bonn, Not set

Local Institution - 0288, Essen, Not set

Local Institution - 0286, Gauting, Not set

All India Institute of Medical Sciences, New Delhi, Delhi

Local Institution - 0448, New Delhi, Delhi

Rajiv Gandhi Cancer Institute And Research Centre, New Delhi, Delhi

Local Institution - 0333, Bengaluru, Karnataka

Local Institution - 0331, Thiruvananthapuram, Kerala

Mumbai Oncocare Centre Vile Parle, Mumbai, Maharashtra

Local Institution - 0336, Mumbai, Maharashtra

Local Institution - 0453, Secunderabad, Telangana

Narayana Superspecialty Hospital, Howrah, West Bengal

Local Institution - 0367, Dublin, Not set

Local Institution - 0028, Dublin, Not set

Local Institution - 0029, Dublin, Not set

Local Institution - 0027, Dublin, Not set

Local Institution - 0400, Ravenna, Emilia-Romagna

Local Institution - 0045, Monza, Lombardia

Local Institution - 0046, Naples, Napoli

Local Institution - 0049, Naples, Napoli

Local Institution - 0043, Bari, Puglia

Local Institution - 0250, Rome, Roma

Local Institution - 0221, Peschiera del Garda, Verona

Local Institution - 0222, Ravenna, Not set

Local Institution - 0312, Kashiwa, Chiba

University of Occupational and Enviromental Health, Kitakyushu, Fukuoka

Kurume University Hospital, Kurume, Fukuoka

Chugoku Central Hospital, Fukuyama-shi, Hiroshima

National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido

Local Institution - 0449, Yokohama, Kanagawa

Kanagawa cancer center, Yokohama, Kanagawa

Local Institution - 0444, Nankoku, Kochi

Sendai Kousei Hospital, Sendai, Miyagi

Nara Medical University Hospital, Kashihara, Nara

Niigata Cancer Center Hospital, Niigata-shi, Niigata

Kurashiki Central Hospital, Kurashiki, Okayama

Kansai Medical University Hospital, Hirakata, Osaka

Kindai University Hospital- Osakasayama Campus, Osaka-sayama, Osaka

Saitama Medical University International Medical Center, Hidaka, Saitama

Hamamatsu University Hospital, Hamamatsu, Shizuoka

Shizuoka Cancer Center, Nagaizumi-cho,Sunto-gun, Shizuoka

The Cancer Institute Hospital of JFCR, Koto, Tokyo

Hyogo Cancer Center, Akashi, Not set

Fukushima Medical University, Fukushima, Not set

Osaka International Cancer Institute, Osaka, Not set

Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do [Chungbuk]

Gachon University Gil Medical Center, Namdong-gu, Incheon-gwangyeoksi [Incheon]

Chonnam National University Hwasun Hospital, Hwasun, Jeonranamdo

National Cancer Center, Goyang-si, Kyǒnggi-do

Local Institution - 0450, Seongnam-si, Kyǒnggi-do

Local Institution - 0454, Busan, Pusan-Kwangyǒkshi

Severance Hospital, Yonsei University Health System, Seoul, Seoul-teukbyeolsi [Seoul]

Asan Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]

Samsung Medical Center, Seoul, Seoul-teukbyeolsi [Seoul]

Local Institution - 0170, Guadalajara, Jalisco

Local Institution - 0168, Santiago de Queretaro, Querétaro

Local Institution - 0172, Mexico, Not set

Local Institution - 0169, San Luis Potosí, Not set

Local Institution - 0030, Harderwijk, Gelderland

Local Institution - 0193, Heerlen, Limburg

Local Institution - 0196, Den Bosch, Noord-Brabant

Local Institution - 0195, Zwolle, Overijssel

Local Institution - 0036, Leiden, Zuid-Holland

Local Institution - 0315, The Hague, Zuid-Holland

Local Institution - 0033, Arnhem, Not set

Local Institution - 0032, Groningen, Not set

Local Institution - 0407, Tauranga, Bay Of Plenty

Local Institution - 0447, Tauranga, Bay Of Plenty

Local Institution - 0405, Auckland, Not set

Local Institution - 0425, Dunedin, Not set

Local Institution - 0406, Wellington, Not set

Local Institution - 0259, Warsaw, Mazowieckie

Local Institution - 0255, Konin, Wielkopolskie

Local Institution - 0261, Poznan, Wielkopolskie

Local Institution - 0256, Poznań, Wielkopolskie

Local Institution - 0257, Koszalin, Zachodniopomorskie

Local Institution - 0260, Bydgoszcz, Not set

Local Institution - 0258, Prabuty, Not set

Local Institution - 0254, Łódź, Łódzkie

Local Institution - 0402, Lisbon, Lisboa

Local Institution - 0404, Coimbra, Not set

Local Institution - 0403, Porto, Not set

Local Institution - 0401, Porto, Not set

Local Institution - 0296, Bucharest, București

Local Institution - 0298, Bucharest, București

Local Institution - 0299, Florești, Cluj

Local Institution - 0295, Craiova, Dolj

Local Institution - 0297, Ploiești, Prahova

Local Institution - 0301, Cluj, Not set

Local Institution - 0300, Iași, Not set

Local Institution - 0408, Riyadh, Ar Riyāḑ

Local Institution - 0440, Dammam, Ash Sharqīyah

Local Institution - 0409, Jeddah, Makkah Al Mukarramah

Local Institution - 0429, Johannesburg, GP

Local Institution - 0432, Pretoria, GP

Local Institution - 0427, Sandton, GP

Local Institution - 0431, Soweto, GP

Local Institution - 0428, Cape Town, Western Cape

Local Institution - 0270, A Coruña, A Coruña [La Coruña]

Local Institution - 0264, Barcelona, Barcelona [Barcelona]

Hospital de la Santa Creu i Sant Pau, Barcelona, Catalunya [Cataluña]

Local Institution - 0267, L'Hospitalet de Llobregat, Catalunya [Cataluña]

Local Institution - 0414, Palma, Illes Balears [Islas Baleares]

Local Institution - 0413, Madrid, Madrid, Comunidad De

Local Institution - 0265, Madrid, Madrid, Comunidad De

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Comunidad De

Local Institution - 0411, Valencia, València

Local Institution - 0266, Málaga, Not set

Hospital Universitario Virgen Del Rocio, Sevilla, Not set

Local Institution - 0269, València, Not set

Local Institution - 0341, Bellinzona, Ticino

Local Institution - 0291, Lausanne, Vaud

Local Institution - 0290, Basel, Not set

Local Institution - 0398, Münsterlingen, Not set

Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung Niao Sung Dist, Kaohsiung

Taipei Medical University Shuang Ho Hospital, New Taipei, Not set

Taichung Veterans General Hospital, Taichung, Not set

National Taiwan University Hospital, Taipei, Not set

Taipei Veterans General Hospital, Taipei, Not set

Local Institution - 0361, Adana, Not set

Local Institution - 0365, Adana, Not set

Local Institution - 0383, Ankara, Not set

Local Institution - 0362, Ankara, Not set

Local Institution - 0410, Istanbul, Not set

Local Institution - 0364, Istanbul, Not set

Local Institution - 0441, Exeter, Devon

Ninewells Hospital and Medical School, Dundee, Dundee City

Forth Valley Royal Hospital, Larbert, Falkirk

Local Institution - 0189, Glasgow, Glasgow City

Local Institution - 0021, London, Kensington And Chelsea

St Bartholomew's Hospital, London, London, City Of

Local Institution - 0001, London, London, City Of

Local Institution - 0020, Manchester, Not set

Local Institution - 0463, Reading, Not set

Local Institution - 0024, Wirral, Not set

Conditions: Non-small Cell Lung Cancer

Learn More ›